5-Chloromethyloxazolidin-2-one → HCID 67298101, 화합물
반응식
Cl[CH2:2][CH:3]1[O:7][C:6](=[O:8])[NH:5][CH2:4]1.[CH3:9][NH:10][C:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([C:21]3[CH:22]=[C:23]([OH:27])[CH:24]=[CH:25][CH:26]=3)[CH:19]=2)[N:14]=[C:13]([C:28]2[CH:29]=[N:30][CH:31]=[CH:32][CH:33]=2)[N:12]=1.CCN(P1(N(C)CCCN1C)=NC(C)(C)C)CC>CN1C(=O)CCC1.CO>[CH3:9][NH:10][C:11]1[C:20]2[C:15](=[CH:16][CH:17]=[C:18]([C:21]3[CH:22]=[C:23]([CH:24]=[CH:25][CH:26]=3)[O:27][CH2:2][CH:3]3[O:7][C:6](=[O:8])[NH:5][CH2:4]3)[CH:19]=2)[N:14]=[C:13]([C:28]2[CH:29]=[N:30][CH:31]=[CH:32][CH:33]=2)[N:12]=1참가 물질
6
반응 조건
- 온도
- 90 °C
실험 절차
To 5-(chloromethyl)oxazolidin-2-one (45 μmol) was added the solution of 3-(4-(methylamino)-2-(pyridin-3-yl)quinazolin-6-yl)phenol (30 μmol) in NMP (200 μL). PS-BEMP (90 μmol) was added to the vials by resin dispenser. After the reaction mixture was heated at 90° C. for 12 h, the residue was diluted with methanol and purified by PREP-HPLC Condition D. The target fraction was lyophilized to afford the titled compound whose structure was finally confirmed by LCMS using LCMS Method E.
후처리
- custompurified by PREP-HPLC Condition D
출처 및 근거
- ORD 기록
- ord-94e609f8406b48db9ca1eaa19705cdd6
- 출처 데이터셋
- uspto-grants-2015_07
- 특허 번호
- US09073890B2
반응 노트
불러오는 중…